Manulife (Manufacturers Life Insurance)’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$28.8M Buy
119,460
+5,458
+5% +$1.32M 0.03% 517
2025
Q1
$27.8M Buy
114,002
+6,807
+6% +$1.66M 0.03% 514
2024
Q4
$35.2M Buy
107,195
+20,413
+24% +$6.71M 0.03% 460
2024
Q3
$29M Buy
86,782
+24,052
+38% +$8.05M 0.03% 517
2024
Q2
$17.1M Sell
62,730
-16,734
-21% -$4.57M 0.02% 655
2024
Q1
$27.5M Buy
79,464
+5,854
+8% +$2.02M 0.03% 529
2023
Q4
$23.8M Buy
73,610
+55,369
+304% +$17.9M 0.01% 575
2023
Q3
$6.54M Buy
18,241
+2,575
+16% +$923K ﹤0.01% 993
2023
Q2
$5.94M Sell
15,666
-378
-2% -$143K ﹤0.01% 997
2023
Q1
$7.69M Sell
16,044
-295
-2% -$141K ﹤0.01% 901
2022
Q4
$6.87M Buy
16,339
+266
+2% +$112K ﹤0.01% 921
2022
Q3
$6.7M Sell
16,073
-1,119
-7% -$467K ﹤0.01% 923
2022
Q2
$8.51M Buy
17,192
+1,405
+9% +$695K 0.01% 880
2022
Q1
$8.89M Sell
15,787
-3,386
-18% -$1.91M 0.01% 950
2021
Q4
$14.5K Sell
19,173
-1,643
-8% -$1.24K 0.01% 783
2021
Q3
$15.5M Sell
20,816
-647
-3% -$483K 0.01% 754
2021
Q2
$13.8M Buy
21,463
+1,044
+5% +$673K 0.01% 819
2021
Q1
$11.7M Sell
20,419
-1,568
-7% -$896K 0.01% 884
2020
Q4
$12.8M Sell
21,987
-562
-2% -$328K 0.01% 793
2020
Q3
$11.6M Sell
22,549
-9,753
-30% -$5.03M 0.01% 736
2020
Q2
$14M Sell
32,302
-15,915
-33% -$6.88M 0.01% 649
2020
Q1
$16.9M Buy
48,217
+11,959
+33% +$4.19M 0.02% 539
2019
Q4
$13.4M Sell
36,258
-119,117
-77% -$44.1M 0.01% 691
2019
Q3
$51.9M Sell
155,375
-9,806
-6% -$3.28M 0.06% 303
2019
Q2
$51.6M Buy
165,181
+29,688
+22% +$9.28M 0.06% 296
2019
Q1
$41.4M Sell
135,493
-88,634
-40% -$27.1M 0.04% 354
2018
Q4
$52M Buy
224,127
+43,538
+24% +$10.1M 0.07% 279
2018
Q3
$56.5M Sell
180,589
-26,161
-13% -$8.19M 0.06% 297
2018
Q2
$59.7M Sell
206,750
-17,755
-8% -$5.12M 0.07% 294
2018
Q1
$56.1M Buy
224,505
+11,627
+5% +$2.91M 0.06% 300
2017
Q4
$50.8M Sell
212,878
-33,070
-13% -$7.89M 0.05% 335
2017
Q3
$54.7M Buy
245,948
+15,856
+7% +$3.52M 0.07% 291
2017
Q2
$52.1M Sell
230,092
-74,805
-25% -$16.9M 0.06% 307
2017
Q1
$60.8M Buy
304,897
+10,143
+3% +$2.02M 0.08% 264
2016
Q4
$53.7M Sell
294,754
-2,279
-0.8% -$415K 0.08% 249
2016
Q3
$48.7M Buy
297,033
+14,254
+5% +$2.33M 0.07% 259
2016
Q2
$40.4M Buy
282,779
+761
+0.3% +$109K 0.06% 278
2016
Q1
$38.5M Buy
282,018
+16,295
+6% +$2.22M 0.03% 297
2015
Q4
$36.8K Sell
265,723
-2,896
-1% -$402 0.04% 301
2015
Q3
$36.1K Buy
268,619
+83,426
+45% +$11.2K 0.04% 311
2015
Q2
$27.9K Buy
185,193
+5,829
+3% +$878 0.03% 375
2015
Q1
$24.2K Sell
179,364
-40,639
-18% -$5.49K 0.03% 395
2014
Q4
$26.5K Buy
220,003
+134,905
+159% +$16.3K 0.04% 348
2014
Q3
$9.65K Sell
85,098
-6,355
-7% -$721 0.01% 641
2014
Q2
$10.9M Sell
91,453
-14,895
-14% -$1.78M 0.02% 603
2014
Q1
$13.6K Buy
106,348
+774
+0.7% +$99 0.02% 551
2013
Q4
$13.1K Buy
105,574
+3,745
+4% +$463 0.02% 555
2013
Q3
$12K Buy
101,829
+12,588
+14% +$1.48K 0.02% 559
2013
Q2
$10M Buy
+89,241
New +$10M 0.02% 563